These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7238047)
1. On the mechanism of action of a new pregnancy-terminating agent. Part I: Effects of prostaglandin F2 alpha metabolism in the rat and the hamster. Luzzani F; Galliani G Contraception; 1981 Mar; 23(3):325-33. PubMed ID: 7238047 [TBL] [Abstract][Full Text] [Related]
2. Effect of day of pregnancy and pregnancy terminating agents on prostaglandin synthesis and metabolism and histamine metabolism in the rat utero-placental fetal complex and lung. Lerner LJ; Carminati P J Steroid Biochem; 1977 May; 8(5):395-402. PubMed ID: 599916 [No Abstract] [Full Text] [Related]
4. Effects of ketoprofen on release of prostaglandin F2 alpha from uterus of rat in perinatal period. Ueno K; Masumura H; Kawamoto H; Kitagawa H Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):173-82. PubMed ID: 3480546 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy terminating activity of a new non-hormonal anti-fertility agent, 2-(3-ethoxy-phenyl)-5,6-dihydro-s-triazole [5,1-a] isoquinoline (DL 204-IT) in the rat and the hamster. Studies on the factors affecting its activity. Galliani G; Gallico L; Cattaneo C; Assandri A Arzneimittelforschung; 1980; 30(6):972-7. PubMed ID: 7191276 [TBL] [Abstract][Full Text] [Related]
6. [Prostaglandins in human pregnancy and labor--studies on the levels of PGF2 alpha metabolites and in vitro production of PGE and PGF by uterus and placenta during human pregnancy and labor (author's transl)]. Yasumizu T Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):1-10. PubMed ID: 7229446 [TBL] [Abstract][Full Text] [Related]
7. Comparison of three subcutaneous modes of prostaglandin F2 alpha administration for pregnancy termination in the hamster. Wilks JW Prostaglandins; 1982 Dec; 24(6):837-42. PubMed ID: 6962972 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of clomiphene citrate on the conversion of 13,14-dihydro-15-keto-prostaglandin F2 alpha to 13,14-dihydro-prostaglandin F2 alpha in rat ovary. Inazu N; Kogo H; Satoh T Jpn J Pharmacol; 1986 Dec; 42(4):487-91. PubMed ID: 3807050 [TBL] [Abstract][Full Text] [Related]
9. Effect of L-10503 (a novel antifertility compound) on the synthesis and metabolism of prostaglandins in vivo and in vitro in the pregnant rat placenta, ovary, kidney, and lung, and in rat deciduoma. Lerner LJ; Carminati P Adv Prostaglandin Thromboxane Res; 1976; 2():645-53. PubMed ID: 983866 [No Abstract] [Full Text] [Related]
10. 2-(1,1'-Biphenyl-4-yl)- 1,2,4-triazole[5,1-a] isoquinoline (L 14105), a potential orally active contragestational agent for the bitch: studies in the rat, hamster and dog. Galliani G; Guzzi U; Tarzia G; Assandri A J Vet Pharmacol Ther; 1986 Sep; 9(3):246-53. PubMed ID: 3761415 [TBL] [Abstract][Full Text] [Related]
11. Luteolytic potency of PGD and PGF2 alpha derivatives. Brambaifa N Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):319-25. PubMed ID: 3164283 [TBL] [Abstract][Full Text] [Related]
12. Luteolytic potency of 16-phenoxy-derivatives of prostaglandin F2 alpha. Brambaifa N Experientia; 1988 Jan; 44(1):45-7. PubMed ID: 3162421 [TBL] [Abstract][Full Text] [Related]
14. Catabolism of prostaglandin F2 alpha in rat ovary : differences between ovarian and uterine tissues. Aizawa Y; Inazu N; Kogo H Prostaglandins; 1980 Jul; 20(1):95-103. PubMed ID: 7403575 [TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandins, dibutyryl cAMP, LHRH, estrogens, progesterone, and potassium on output of prostaglandin F2 alpha, 13, 14-dihydro-15-keto-prostaglandin F2 alpha, hCG, estradiol, and progesterone by placental minces. Haning RV; Choi L; Kiggens AJ; Kuzma DL Prostaglandins; 1982 Oct; 24(4):495-506. PubMed ID: 6294747 [TBL] [Abstract][Full Text] [Related]
16. DL 111, a new non-hormonal antifertility agent: contragestational and kinetic profile in baboons. Galliani G; Assandri A; Lerner LJ; Omodei-Salè A; Lancini G; Nock PE; Grant AM Contraception; 1982 Aug; 26(2):165-79. PubMed ID: 7140293 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of prostaglandin F2 alpha in the fetal circulation of the human term placenta in vitro. Ekblad U; Erkkola R; Uotila P Gynecol Obstet Invest; 1984; 18(6):306-10. PubMed ID: 6596283 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics-activity relationships of a new non-hormonal antifertility agent: 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1, 2,4-triazole, in the rat and the hamster. Assandri A; Perazzi A; Omodei-Salé A; Sartori G; Galliani G Eur J Drug Metab Pharmacokinet; 1983; 8(1):9-16. PubMed ID: 6861799 [TBL] [Abstract][Full Text] [Related]
19. Effects of dibutyryl cAMP, LHRH, and aromatase inhibitor on simultaneous outputs of prostaglandin F2 alpha, and 13,14-dihydro-15-keto-prostaglandin F2 alpha by term placental explants. Haning RV; Choi L; Kiggens AJ; Kuzma DL; Summerville JW Prostaglandins; 1982 Jan; 23(1):29-40. PubMed ID: 6278539 [TBL] [Abstract][Full Text] [Related]
20. 2-(Aminomethyl)-2-decarboxyprostaglandin F2 alpha type analogs. Nelson NA; Sih JC; Jackson RW; Miller WL; Cornette JC Prostaglandins; 1979 Mar; 17(3):441-9. PubMed ID: 572982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]